Submitted by Anonymous (not verified) on 6 November 2023 - 13:08
Human medicines European public assessment report (EPAR): Skytrofa (previously Lonapegsomatropin Ascendis Pharma), lonapegsomatropin, Growth and Development, Date of authorisation: 11/01/2022, Revision: 4, Status: Authorised
Source: